A modern clinic for at-home treatments
(857) 240-1080
Holiday Sale! Get started today for only
$49 $4.99
Written and prepared by:
Kelly Bruton, Paul Spill, Shabana Vohra, Owen Baribeau, Saba Manzoor, Siyon Gadkar, Malcolm Davidson, Tina D. Walker, Yosef Ellenbogen, Alexandra Florescu, Jianping Wen, Derek K. Chu, Susan Waserman, Rodrigo Jiménez-Saiz, Slava Epelman, Clinton Robbins, Manel Jordana
Delve into how interrupting the reactivation of immunological memory can reprogram allergy and avert anaphylaxis. This study identifies the IL-4/IL-13 signaling pathway as critical in IgE recall responses. By blocking IL-4Ra, researchers prevented IgE production and reprogrammed pathogenic responses, offering a promising therapeutic approach for treating food allergies and preventing severe allergic reactions.
Study shows how blocking IL-4/IL-13 reprograms immune response and prevents anaphylaxis in peanut allergy.
Utilizing single-cell RNA sequencing to uncover IL-4/IL-13's role in IgE recall and allergy reprogramming.
Analysis of IL-4/IL-13 signaling in peanut-specific B and T cells and its impact on IgE regeneration.
Study demonstrates that blocking IL-4Ra inhibits IgE production and prevents peanut-induced anaphylaxis.
Blocking IL-4/IL-13 signaling reprograms Th2 responses, reducing IgE and preventing allergic reactions.
Long-Term Effects of IL-4Ra Blockade in Allergy
Insurance covers clinical consultations.
Subscription fee (from $59/month not billed to insurance) covers immunotherapy, shipping & related costs.